TMA Molecular Beacon Kit for Group A Strep Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for detecting Group A streptococci, such as DNA probe assays, face limitations in sensitivity, precision, and speed, particularly in identifying low target copy levels and requiring time-consuming serological grouping for definitive identification.
Innovation Solution
A kit containing specific primers and probes designed to amplify and detect Streptococcus pyogenes nucleic acid sequences, utilizing real-time transcription-mediated amplification (TMA) and molecular beacons for enhanced sensitivity, precision, and rapid detection, allowing for both qualitative and quantitative measurements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If DNA probe assays are used for detecting Group A streptococci, then identification accuracy is improved, but detection sensitivity and speed deteriorate
Solution Approach 1:
The patent combines nucleic acid amplification (TMA) with molecular beacon detection in a single integrated system. The amplification step increases target copy number to enhance sensitivity, while the molecular beacon provides real-time fluorescent detection for rapid and accurate identification, resolving the contradiction between sensitivity and accuracy
Solution Approach 2:
Molecular beacons serve as intermediary probes that hybridize to amplified target sequences. These beacons contain fluorophore-quencher pairs that generate detectable signals only upon target binding, enabling highly sensitive and specific detection without requiring time-consuming serological confirmation
2Measurement precision
If traditional serological grouping is used for definitive identification, then identification accuracy is improved, but detection time increases
Solution Approach 1:
The patent replaces the mechanical and time-intensive process of serological grouping with a molecular biology-based amplification and fluorescent detection system. The TMA reaction amplifies target DNA exponentially, and molecular beacons provide real-time fluorescent readout, eliminating the need for time-consuming antibody-based serological confirmation while maintaining high identification accuracy
3Measurement precision
If DNA probe assays are used, then non-subjective identification is improved, but detection speed for low target copy levels deteriorates
Solution Approach 1:
The patent performs preliminary nucleic acid amplification (TMA) before detection. This preliminary action increases the concentration of target sequences from low copy numbers to detectable levels, enabling rapid and objective identification that would be impossible with direct probing of low-abundance targets
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The kit significantly improves the detection of Group A streptococci by increasing sensitivity, precision, and speed, enabling rapid identification from biological samples with low target copy levels, and providing a more efficient diagnostic process compared to traditional methods.
Implementation Method 1
utilizing real-time transcription-mediated amplification (TMA) and molecular beacons for enhanced sensitivity, precision, and rapid detection
Implementation Method 2
utilizing real-time transcription-mediated amplification (TMA) and molecular beacons for enhanced sensitivity, precision, and rapid detection
Data Source
AI summary
Compositions, methods and kits for detecting Group A streptococci. Particularly described are oligonucleotides that are useful as amplification primers and hybridization probes for detecting very low levels of Group A streptococci nucleic acids.